Athersys Gets Rights to Minnesota Stem Cells

genomeweb
360dx

Athersys Gets Rights to Minnesota Stem Cells

Dec 11, 2002

NEW YORK, Dec. 11-Athersys has obtained exclusive rights to University of Minnesota stem cell technology in order to study stem cell differentiation and develop new therapeutics, the company said this morning.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

ASHG: RNA Sequencing Can Improve Diagnostic Yield of Exome, Genome Tests
People in the News: Mary Padbury, Katherine Bach Kalin, Daniel Kolk, More
Low-Frequency Genetic Variations Contribute to Multiple Sclerosis Risk
In Brief This Week: Bruker, OneOme, Becton Dickinson, and More
ASHG: Australian Newborn WES Project Combines Hearing Loss Dx With Optional Secondary Results
Cowen Initiates Coverage of PacBio at Outperform

The Scan

Sharing, But Kinda Sorta

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

Upward of One Hundred

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

This Week in Science

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

Structural Biologist Leads India's CSIR

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

Main menu